These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9707312)

  • 21. Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate.
    Andersen LP; Colding H; Kristiansen JE
    Int J Antimicrob Agents; 2000 Apr; 14(3):231-4. PubMed ID: 10773493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
    Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating Helicobacter pylori.
    Howden CW; Hunt RH
    Arch Intern Med; 1998 Nov; 158(21):2396-8. PubMed ID: 9827792
    [No Abstract]   [Full Text] [Related]  

  • 24. In-vitro activity of lansoprazole against Helicobacter pylori.
    Figura N; Crabtree JE; Dattilo M
    J Antimicrob Chemother; 1997 May; 39(5):585-90. PubMed ID: 9184356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined activity of azithromycin and lansoprazole against Helicobacter pylori.
    Trautmann M; Riediger C; Möricke A; Vogt K; Bohr U; Glasbrenner B
    Helicobacter; 1999 Jun; 4(2):113-20. PubMed ID: 10382125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
    Langtry HD; Wilde MI
    Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method.
    Fera MT; Carbone M; De Sarro A; Blandino G; Riggio G; Cusumano V; De Sarro GB; Ciliberti FA
    Int J Antimicrob Agents; 1998 Nov; 10(4):285-9. PubMed ID: 9916902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
    Blum RA; Shi H; Karol MD; Greski-Rose PA; Hunt RH
    Clin Ther; 1997; 19(5):1013-23. PubMed ID: 9385488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
    Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
    Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
    Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells.
    Peddicord TE; Olsen KM; Collier DS
    Crit Care Med; 1999 Jan; 27(1):90-4. PubMed ID: 9934899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori.
    Midolo PD; Lambert JR; Kerr TG; Tee W
    Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):832-4. PubMed ID: 10614963
    [No Abstract]   [Full Text] [Related]  

  • 34. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth.
    Nakajima N; Kuwayama H; Iwasaki A; Arakawa Y
    J Clin Gastroenterol; 1995; 20 Suppl 2():S90-2. PubMed ID: 7594352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
    Meining A; Kiel G; Stolte M
    Aliment Pharmacol Ther; 1998 Aug; 12(8):735-40. PubMed ID: 9726386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of ranitidine and lansoprazole in short-term low-dose triple therapy for Helicobacter pylori infection.
    Kihira K; Satoh K; Saifuku K; Taniguchi Y; Takimoto T; Yamamoto H; Ido K; Yoshida Y; Kimura K
    Aliment Pharmacol Ther; 1997 Jun; 11(3):511-4. PubMed ID: 9218074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
    Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
    Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of lansoprazole against Helicobacter pylori.
    Megraud F; Boyanova L; Lamouliatte H
    Lancet; 1991 Jun; 337(8755):1486. PubMed ID: 1675355
    [No Abstract]   [Full Text] [Related]  

  • 40. Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
    Piotrowski J; Majka J; Piotrowski E; Murty VL; Gabryelewicz A; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1994 Nov; 34(5):875-81. PubMed ID: 7535617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.